Infectologia
M-A | Acurácia da tomografia por emissão de pósitrons/tomografia computadorizada com fluorodeoxiglicose (FDG PET/CT) para diagnóstico de infecções articulares periprotéticas.
22 Jun, 2022 | 21:07hSuplemento | Estratégias digitais e mídias sociais em doenças infecciosas.
22 Jun, 2022 | 20:38hPágina principal: Digital Strategy and Social Media in Infectious Diseases – Clinical Infectious Diseases
Digital Strategy and Social Media for Infectious Diseases
The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education
Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club
Surgeons, Infectious Diseases, and Twitter Hit a Home Run for Antibiotic Stewardship
Go V.I.R.A.L.: Social Media Engagement Strategies in Infectious Diseases
Atualização da OMS sobre o surto de varíola dos macacos.
21 Jun, 2022 | 13:15hMulti-country monkeypox outbreak: situation update – World Health Organization
Conteúdos relacionados:
Monkeypox Genital Lesions – New England Journal of Medicine
Monkeypox vaccination begins — can the global outbreaks be contained? – Nature
Incubation period for monkeypox: Estimates from the Netherlands.
‘Discriminatory and stigmatizing’: Scientists push to rename monkeypox viruses – STAT
Rename monkeypox strains to remove geographic stigma, researchers say – Science
2022 Monkeypox and Orthopoxvirus Outbreak Global Map – Centers for Disease Control and Prevention
As monkeypox threat grows, scientists debate best vaccine strategy – Science
Monkeypox is a new global threat. African scientists know what the world is up against – Science
Experts highlight sexual aspect of monkeypox spread – CIDRAP
What to Know About Monkeypox – JAMA
Multi-country monkeypox outbreak in non-endemic countries: Update – World Health Organization
Monkeypox outbreaks: 4 key questions researchers have – Nature
Study reports first use of antivirals in monkeypox patients – Lancet
Surveillance, case investigation and contact tracing for Monkeypox – World Health Organization
Laboratory testing for the monkeypox virus: Interim guidance – World Health Organization
A Novel International Monkeypox Outbreak – Annals of Internal Medicine
EU health agency warns monkeypox could become endemic in Europe if outbreak continues – STAT
Monkeypox cases increase across Europe, North America – CIDRAP
Multi-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Estudo randomizado | Uma estratégia de restrição de fluidos intravenosos não melhora os desfechos em pacientes em UTI com choque séptico.
21 Jun, 2022 | 13:14hRestriction of Intravenous Fluid in ICU Patients with Septic Shock – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: No Fewer Deaths Seen With Restricted IV Fluid for Septic Shock – HealthDay
Conteúdos relacionados:
Fluid administration and monitoring in ARDS: which management? – Intensive Care Medicine
Comentário no Twitter
In this trial, a restrictive approach to intravenous fluid administration in critically ill patients with septic shock did not reduce mortality. #CCR22 https://t.co/UfY1936Qwb pic.twitter.com/FtSaDIIroj
— NEJM (@NEJM) June 17, 2022
Diretriz provisória da OMS sobre o uso de vacinas contra COVID-19 atualizadas para as variantes.
21 Jun, 2022 | 13:12hVer também: Interim statement on the composition of current COVID-19 vaccines – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
Current #COVID19 vaccines provide high levels of protection against severe disease and death from all variants. They should continue to be used.
🆕 interim statement:https://t.co/bVzzx1HnG2 pic.twitter.com/CJlAJqFr3C
— World Health Organization (WHO) (@WHO) June 17, 2022
Estudo de caso-controle | Risco de COVID longa associado com variantes Delta vs. Ômicron do SARS-CoV-2.
21 Jun, 2022 | 13:06hRisk of long COVID associated with delta versus omicron variants of SARS-CoV-2 – The Lancet
Comunicado de imprensa: Long COVID risk less during Omicron compared to Delta, study finds – King’s College London
Comentários:
Omicron less likely to lead to long COVID, study finds – CIDRAP
Covid-19: Long covid risk is lower with omicron than delta, researchers find – The BMJ
Comentário no Twitter
Substantial (~50-75%) reduction of #LongCovid with Omicron compared with Delta variant, magnitude influenced by age and time since vaccination @TheLancet https://t.co/shAzJn8WSj pic.twitter.com/bXoct0sXd1
— Eric Topol (@EricTopol) June 17, 2022
Estudo de consenso | Estabelecido de desfechos para a condição pós-COVID-19 para uso na prática clínica e em pesquisas.
21 Jun, 2022 | 13:05hComunicado de imprensa: Key outcomes of Long COVID identified in international consensus study – King’s College London
Comentário convidado: Post-COVID-19 condition in children: a COS is urgently needed – The Lancet Respiratory Medicine
Comentário no Twitter
NEW POSITION PAPER—A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research
From Daniel Munblit & co https://t.co/zAxQ1ww6bT pic.twitter.com/WIitohP3Xo
— The Lancet Respiratory Medicine (@LancetRespirMed) June 15, 2022
Dicas para Covid longa: cientistas se esforçam para desvendar o que determina os sintomas incapacitantes.
21 Jun, 2022 | 13:03h[Preprint] Estudo randomizado aberto | Baricitinibe é não inferior ao tocilizumabe em pacientes internados com COVID-19 grave.
21 Jun, 2022 | 13:01hConteúdos relacionados:
WHO recommends two new drugs to treat COVID-19 – World Health Organization
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine
Comentário no Twitter
Preprint⚡⚡
Baricitinib Vs Tocilizumab open label RCT
Baricitinib was non-inferior to tocilizumab with regards to the composite outcome of mechanical ventilation or death by day 28 and the time to discharge by day 28 in patients with severe #COVID19 https://t.co/sQkhATkjEd— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) June 16, 2022